

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 9.85540071 |
| 2 | citrulline biosynthetic process (GO:0019240) | 9.41894021 |
| 3 | adhesion of symbiont to host (GO:0044406) | 8.90658654 |
| 4 | hair follicle morphogenesis (GO:0031069) | 8.63382651 |
| 5 | peptide cross-linking (GO:0018149) | 8.22232409 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.28306832 |
| 7 | intermediate filament cytoskeleton organization (GO:0045104) | 6.81824583 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.77211881 |
| 9 | negative regulation of cell killing (GO:0031342) | 6.76976234 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.76976234 |
| 11 | intermediate filament-based process (GO:0045103) | 6.60475684 |
| 12 | citrulline metabolic process (GO:0000052) | 6.23977782 |
| 13 | response to interleukin-15 (GO:0070672) | 5.96475512 |
| 14 | epidermis development (GO:0008544) | 5.96462797 |
| 15 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.88270568 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.87507084 |
| 17 | negative thymic T cell selection (GO:0045060) | 5.80880018 |
| 18 | cell wall macromolecule catabolic process (GO:0016998) | 5.77812114 |
| 19 | cell wall macromolecule metabolic process (GO:0044036) | 5.77812114 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.72024204 |
| 21 | negative T cell selection (GO:0043383) | 5.70746501 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 5.60132243 |
| 23 | cellular response to interleukin-15 (GO:0071350) | 5.60056854 |
| 24 | hair cycle process (GO:0022405) | 5.52981286 |
| 25 | molting cycle process (GO:0022404) | 5.52981286 |
| 26 | keratinocyte differentiation (GO:0030216) | 5.47822476 |
| 27 | leukocyte aggregation (GO:0070486) | 5.31854608 |
| 28 | peptidyl-arginine modification (GO:0018195) | 5.26677458 |
| 29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.23594281 |
| 30 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.08310793 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.00743722 |
| 32 | activated T cell proliferation (GO:0050798) | 4.96738618 |
| 33 | thymic T cell selection (GO:0045061) | 4.75011650 |
| 34 | positive thymic T cell selection (GO:0045059) | 4.72933236 |
| 35 | positive T cell selection (GO:0043368) | 4.66210710 |
| 36 | hemidesmosome assembly (GO:0031581) | 4.63857029 |
| 37 | T cell selection (GO:0045058) | 4.61970795 |
| 38 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.56184491 |
| 39 | positive regulation of granulocyte differentiation (GO:0030854) | 4.50499359 |
| 40 | skin morphogenesis (GO:0043589) | 4.45524513 |
| 41 | establishment of skin barrier (GO:0061436) | 4.38889106 |
| 42 | epidermal cell differentiation (GO:0009913) | 4.29734566 |
| 43 | cellular extravasation (GO:0045123) | 4.27224872 |
| 44 | T cell migration (GO:0072678) | 4.19735083 |
| 45 | regulation of T cell tolerance induction (GO:0002664) | 4.12318276 |
| 46 | negative regulation of T cell mediated immunity (GO:0002710) | 4.11566785 |
| 47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.10740549 |
| 48 | molting cycle (GO:0042303) | 35.9713619 |
| 49 | hair cycle (GO:0042633) | 35.9713619 |
| 50 | regulation of water loss via skin (GO:0033561) | 3.94208201 |
| 51 | tolerance induction (GO:0002507) | 3.92238392 |
| 52 | detection of bacterium (GO:0016045) | 3.85508700 |
| 53 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.83865452 |
| 54 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.83865452 |
| 55 | modulation by symbiont of host immune response (GO:0052553) | 3.83865452 |
| 56 | positive regulation by symbiont of host defense response (GO:0052509) | 3.83865452 |
| 57 | modulation by symbiont of host defense response (GO:0052031) | 3.83865452 |
| 58 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.83865452 |
| 59 | detection of other organism (GO:0098543) | 3.78005935 |
| 60 | keratinocyte development (GO:0003334) | 3.70198575 |
| 61 | tooth mineralization (GO:0034505) | 3.69529705 |
| 62 | negative regulation of phagocytosis (GO:0050765) | 3.69470804 |
| 63 | regulation of tolerance induction (GO:0002643) | 3.66494828 |
| 64 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.63722820 |
| 65 | regulation of granulocyte differentiation (GO:0030852) | 3.61522683 |
| 66 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.57315077 |
| 67 | B cell receptor signaling pathway (GO:0050853) | 3.55053571 |
| 68 | positive regulation of tolerance induction (GO:0002645) | 3.54725581 |
| 69 | regulation of B cell differentiation (GO:0045577) | 3.51837803 |
| 70 | positive regulation of B cell differentiation (GO:0045579) | 3.43535969 |
| 71 | T cell homeostasis (GO:0043029) | 3.43288850 |
| 72 | neutrophil activation involved in immune response (GO:0002283) | 3.40422520 |
| 73 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.40202575 |
| 74 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 3.39899803 |
| 75 | mast cell activation (GO:0045576) | 3.36977543 |
| 76 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.35943913 |
| 77 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.35893858 |
| 78 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.31138973 |
| 79 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.31138973 |
| 80 | signal complex assembly (GO:0007172) | 3.30102051 |
| 81 | T cell receptor signaling pathway (GO:0050852) | 3.29294238 |
| 82 | natural killer cell differentiation (GO:0001779) | 3.25226776 |
| 83 | hair follicle development (GO:0001942) | 3.24499321 |
| 84 | histone H3-K36 demethylation (GO:0070544) | 3.22203419 |
| 85 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.21982784 |
| 86 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.21727568 |
| 87 | positive regulation of hair cycle (GO:0042635) | 3.20784428 |
| 88 | positive regulation of hair follicle development (GO:0051798) | 3.20784428 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.19148342 |
| 90 | macrophage activation involved in immune response (GO:0002281) | 3.18765685 |
| 91 | regulation of regulatory T cell differentiation (GO:0045589) | 3.18019214 |
| 92 | regulation of keratinocyte differentiation (GO:0045616) | 3.16145201 |
| 93 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.13181593 |
| 94 | negative regulation of interleukin-12 production (GO:0032695) | 3.09603338 |
| 95 | response to muramyl dipeptide (GO:0032495) | 3.08881178 |
| 96 | leukocyte degranulation (GO:0043299) | 3.08184250 |
| 97 | respiratory burst (GO:0045730) | 3.07117723 |
| 98 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.05862325 |
| 99 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.04701966 |
| 100 | Peyers patch development (GO:0048541) | 3.04701966 |
| 101 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.03087052 |
| 102 | regulation of hair follicle development (GO:0051797) | 3.02728426 |
| 103 | alpha-beta T cell differentiation (GO:0046632) | 3.01444396 |
| 104 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.00072268 |
| 105 | interferon-gamma production (GO:0032609) | 2.99888886 |
| 106 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.99092952 |
| 107 | myeloid cell activation involved in immune response (GO:0002275) | 2.96704639 |
| 108 | lymphocyte homeostasis (GO:0002260) | 2.92900089 |
| 109 | positive regulation of interleukin-4 production (GO:0032753) | 2.90034589 |
| 110 | mast cell activation involved in immune response (GO:0002279) | 2.88851145 |
| 111 | mast cell degranulation (GO:0043303) | 2.88851145 |
| 112 | positive regulation of histone deacetylation (GO:0031065) | 2.87833605 |
| 113 | positive regulation of interleukin-2 production (GO:0032743) | 2.85101255 |
| 114 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.85016783 |
| 115 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.84881431 |
| 116 | alpha-beta T cell activation (GO:0046631) | 2.84622671 |
| 117 | type I interferon signaling pathway (GO:0060337) | 2.82683987 |
| 118 | cellular response to type I interferon (GO:0071357) | 2.82683987 |
| 119 | neutrophil activation (GO:0042119) | 2.82661113 |
| 120 | response to type I interferon (GO:0034340) | 2.82427751 |
| 121 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.82419378 |
| 122 | epithelium development (GO:0060429) | 2.82389893 |
| 123 | regulation of histone H3-K27 methylation (GO:0061085) | 2.81806139 |
| 124 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.80229064 |
| 125 | regulation of interleukin-4 production (GO:0032673) | 2.79836951 |
| 126 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.79415181 |
| 127 | regulation of alpha-beta T cell activation (GO:0046634) | 2.79330860 |
| 128 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.79052430 |
| 129 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.77862627 |
| 130 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.77862627 |
| 131 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.76788237 |
| 132 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.74191024 |
| 133 | detection of external biotic stimulus (GO:0098581) | 2.73579785 |
| 134 | gap junction assembly (GO:0016264) | 2.73313468 |
| 135 | bone trabecula formation (GO:0060346) | 2.72987054 |
| 136 | positive regulation of isotype switching (GO:0045830) | 2.72794442 |
| 137 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.71011892 |
| 138 | multicellular organismal water homeostasis (GO:0050891) | 2.67990076 |
| 139 | positive regulation of epidermis development (GO:0045684) | 2.67925577 |
| 140 | regulation of hair cycle (GO:0042634) | 2.66718396 |
| 141 | positive regulation of meiotic cell cycle (GO:0051446) | 2.66071574 |
| 142 | ectoderm development (GO:0007398) | 2.62716460 |
| 143 | atrioventricular valve morphogenesis (GO:0003181) | 2.55618347 |
| 144 | regulation of epidermal cell differentiation (GO:0045604) | 2.47219315 |
| 145 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.41323515 |
| 146 | regulation of epidermis development (GO:0045682) | 2.40828496 |
| 147 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.39598562 |
| 148 | phosphatidylserine metabolic process (GO:0006658) | 2.31449815 |
| 149 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.24679486 |
| 150 | water homeostasis (GO:0030104) | 2.19836779 |
| 151 | negative regulation of cell fate specification (GO:0009996) | 2.18337047 |
| 152 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.17772041 |
| 153 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.15768400 |
| 154 | fatty acid elongation (GO:0030497) | 2.15403042 |
| 155 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.14051353 |
| 156 | wound healing, spreading of epidermal cells (GO:0035313) | 2.12438489 |
| 157 | aging (GO:0007568) | 2.11702790 |
| 158 | cranial suture morphogenesis (GO:0060363) | 2.07367660 |
| 159 | lymph vessel development (GO:0001945) | 2.04026755 |
| 160 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.03485935 |
| 161 | regulation of cardioblast differentiation (GO:0051890) | 2.00042230 |
| 162 | intermediate filament organization (GO:0045109) | 12.5004621 |
| 163 | virion attachment to host cell (GO:0019062) | 10.5291905 |
| 164 | adhesion of symbiont to host cell (GO:0044650) | 10.5291905 |
| 165 | keratinization (GO:0031424) | 10.1442501 |
| 166 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 1.98586603 |
| 167 | positive regulation of monocyte chemotaxis (GO:0090026) | 1.95085611 |
| 168 | negative regulation of epidermis development (GO:0045683) | 1.93785973 |
| 169 | skin development (GO:0043588) | 1.93489918 |
| 170 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 1.92205835 |
| 171 | outflow tract septum morphogenesis (GO:0003148) | 1.91897836 |
| 172 | epithelial cell-cell adhesion (GO:0090136) | 1.90700925 |
| 173 | regulation of keratinocyte proliferation (GO:0010837) | 1.88475138 |
| 174 | cell communication involved in cardiac conduction (GO:0086065) | 1.87927181 |
| 175 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 1.85676504 |
| 176 | regulation of ruffle assembly (GO:1900027) | 1.84606845 |
| 177 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 1.82591733 |
| 178 | myotube differentiation (GO:0014902) | 1.81601906 |
| 179 | ephrin receptor signaling pathway (GO:0048013) | 1.76113892 |
| 180 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 1.73507023 |
| 181 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.73507023 |
| 182 | alditol phosphate metabolic process (GO:0052646) | 1.70851256 |
| 183 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 1.70551043 |
| 184 | cell-substrate junction assembly (GO:0007044) | 1.67604780 |
| 185 | non-canonical Wnt signaling pathway (GO:0035567) | 1.67274711 |
| 186 | regulation of transforming growth factor beta2 production (GO:0032909) | 1.65083157 |
| 187 | cellular modified amino acid biosynthetic process (GO:0042398) | 1.64363144 |
| 188 | cardiac conduction (GO:0061337) | 1.57896868 |
| 189 | coronary vasculature morphogenesis (GO:0060977) | 1.56501185 |
| 190 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 1.55447864 |
| 191 | regulation of cardioblast proliferation (GO:0003264) | 1.54338696 |
| 192 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 1.54338696 |
| 193 | primary alcohol catabolic process (GO:0034310) | 1.53611661 |
| 194 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 1.53206069 |
| 195 | wound healing, spreading of cells (GO:0044319) | 1.52596492 |
| 196 | negative regulation of epidermal cell differentiation (GO:0045605) | 1.50268168 |
| 197 | positive regulation of protein export from nucleus (GO:0046827) | 1.49971141 |
| 198 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 1.49793603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 7.26195674 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.27813737 |
| 3 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 5.02680392 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.34275823 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.32318513 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.88703409 |
| 7 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 3.55560922 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.30157662 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 3.08780381 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 3.02496703 |
| 11 | MAF_26560356_Chip-Seq_TH1_Human | 2.93967279 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.81710963 |
| 13 | UTX_26944678_Chip-Seq_JUKART_Human | 2.81526094 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.81118209 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.69847159 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.68993878 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.68604487 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.64342758 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.61975100 |
| 20 | MAF_26560356_Chip-Seq_TH2_Human | 2.48285665 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.45064866 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.42965889 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.42630680 |
| 24 | CTCF_20526341_ChIP-Seq_ESCs_Human | 2.39899168 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39895831 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38121976 |
| 27 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.37425419 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.35136297 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33773637 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.33532993 |
| 31 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 2.33185636 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.31038545 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.29777996 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.25524581 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 2.15771911 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.15126910 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.13463488 |
| 38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.11713621 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09864599 |
| 40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.08883640 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.07046919 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.04761705 |
| 43 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 12.5857613 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.99694817 |
| 45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.92827635 |
| 46 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.92655297 |
| 47 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.88984913 |
| 48 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.87880301 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87767552 |
| 50 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.79760974 |
| 51 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.79112701 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77963777 |
| 53 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.76223766 |
| 54 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.73019858 |
| 55 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.72986791 |
| 56 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.71253120 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68213806 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67822694 |
| 59 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.64794933 |
| 60 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.63813535 |
| 61 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.61840350 |
| 62 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 1.60624877 |
| 63 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.59669193 |
| 64 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.58840660 |
| 65 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.57788649 |
| 66 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.53785222 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.52217180 |
| 68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.51550646 |
| 69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.51464820 |
| 70 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.50633242 |
| 71 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.48237519 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.47771373 |
| 73 | GATA3_26560356_Chip-Seq_TH2_Human | 1.47760219 |
| 74 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.43992003 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43989408 |
| 76 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.42635462 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.40412282 |
| 78 | ATF3_27146783_Chip-Seq_COLON_Human | 1.39799346 |
| 79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.39719715 |
| 80 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39486613 |
| 81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37780629 |
| 82 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36655779 |
| 83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35092355 |
| 84 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.33981381 |
| 85 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.33981381 |
| 86 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.33151902 |
| 87 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32444139 |
| 88 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31809231 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.31070060 |
| 90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30370055 |
| 91 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.30323112 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.28567874 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28176599 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26110263 |
| 95 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25408288 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25052523 |
| 97 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.24942747 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24541296 |
| 99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23951072 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22658226 |
| 101 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.21373553 |
| 102 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.21248377 |
| 103 | P68_20966046_ChIP-Seq_HELA_Human | 1.19334294 |
| 104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18326951 |
| 105 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.17974513 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17851945 |
| 107 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.17644273 |
| 108 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16958330 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16843782 |
| 110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16722224 |
| 111 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16654914 |
| 112 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16397203 |
| 113 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16296139 |
| 114 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.15827685 |
| 115 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.14486128 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14217053 |
| 117 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.13316453 |
| 118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12791459 |
| 119 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11830078 |
| 120 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10819974 |
| 121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10418134 |
| 122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10385715 |
| 123 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09550698 |
| 124 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.09383900 |
| 125 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.09278614 |
| 126 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08465887 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08154289 |
| 128 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08057999 |
| 129 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07576166 |
| 130 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07190526 |
| 131 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.06385185 |
| 132 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.06245439 |
| 133 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05646599 |
| 134 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05626963 |
| 135 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05231031 |
| 136 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.05169892 |
| 137 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04543391 |
| 138 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.03776886 |
| 139 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01391298 |
| 140 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.01325954 |
| 141 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00205155 |
| 142 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.99114678 |
| 143 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.98618237 |
| 144 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98398994 |
| 145 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98220260 |
| 146 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97913046 |
| 147 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97005326 |
| 148 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96908567 |
| 149 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96454388 |
| 150 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95933883 |
| 151 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95853842 |
| 152 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.95250005 |
| 153 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93731906 |
| 154 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.93645643 |
| 155 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.93134655 |
| 156 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.92861772 |
| 157 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89022826 |
| 158 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.88300255 |
| 159 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88255600 |
| 160 | P300_27268052_Chip-Seq_Bcells_Human | 0.88228095 |
| 161 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88157488 |
| 162 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.87796797 |
| 163 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.87037040 |
| 164 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.84397781 |
| 165 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84397216 |
| 166 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83838632 |
| 167 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.83114343 |
| 168 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.83030192 |
| 169 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.82068015 |
| 170 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.81342843 |
| 171 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.80806887 |
| 172 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.78646529 |
| 173 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.77847272 |
| 174 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77519023 |
| 175 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.76441203 |
| 176 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.76441203 |
| 177 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.76201622 |
| 178 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.75874689 |
| 179 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.75659823 |
| 180 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.74958848 |
| 181 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.73708095 |
| 182 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.71740387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000579_abnormal_nail_morphology | 7.93731513 |
| 2 | MP0002098_abnormal_vibrissa_morphology | 7.54664021 |
| 3 | MP0000647_abnormal_sebaceous_gland | 6.63303829 |
| 4 | MP0002796_impaired_skin_barrier | 5.41021106 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 5.14701875 |
| 6 | MP0005275_abnormal_skin_tensile | 4.83999863 |
| 7 | MP0000383_abnormal_hair_follicle | 4.76971294 |
| 8 | MP0000377_abnormal_hair_follicle | 4.21895507 |
| 9 | MP0010678_abnormal_skin_adnexa | 4.21294213 |
| 10 | MP0003436_decreased_susceptibility_to | 3.93901289 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 3.68995038 |
| 12 | MP0003724_increased_susceptibility_to | 3.64976408 |
| 13 | MP0000427_abnormal_hair_cycle | 3.60892171 |
| 14 | MP0005501_abnormal_skin_physiology | 3.40487898 |
| 15 | MP0001800_abnormal_humoral_immune | 3.25286836 |
| 16 | MP0001835_abnormal_antigen_presentation | 3.16941270 |
| 17 | MP0005671_abnormal_response_to | 3.12390386 |
| 18 | MP0002254_reproductive_system_inflammat | 2.96470239 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.88138960 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.87097480 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.75473052 |
| 22 | MP0001819_abnormal_immune_cell | 2.71466671 |
| 23 | MP0002723_abnormal_immune_serum | 2.64957227 |
| 24 | MP0003303_peritoneal_inflammation | 2.63368599 |
| 25 | MP0002419_abnormal_innate_immunity | 2.62148535 |
| 26 | MP0001790_abnormal_immune_system | 2.61889115 |
| 27 | MP0005387_immune_system_phenotype | 2.61889115 |
| 28 | MP0000685_abnormal_immune_system | 2.60873105 |
| 29 | MP0001216_abnormal_epidermal_layer | 2.55962864 |
| 30 | MP0004381_abnormal_hair_follicle | 2.55300600 |
| 31 | MP0005025_abnormal_response_to | 2.52707804 |
| 32 | MP0000703_abnormal_thymus_morphology | 2.52191913 |
| 33 | MP0002452_abnormal_antigen_presenting | 2.50713088 |
| 34 | MP0000367_abnormal_coat/_hair | 2.41908594 |
| 35 | MP0002398_abnormal_bone_marrow | 2.41133151 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 2.34650924 |
| 37 | MP0003453_abnormal_keratinocyte_physiol | 2.19270521 |
| 38 | MP0000716_abnormal_immune_system | 2.18185233 |
| 39 | MP0004947_skin_inflammation | 2.17481851 |
| 40 | MP0010771_integument_phenotype | 2.16668299 |
| 41 | MP0002405_respiratory_system_inflammati | 2.13706401 |
| 42 | MP0001243_abnormal_dermal_layer | 2.13504527 |
| 43 | MP0009785_altered_susceptibility_to | 2.01837338 |
| 44 | MP0002722_abnormal_immune_system | 2.00746955 |
| 45 | MP0002234_abnormal_pharynx_morphology | 2.00302836 |
| 46 | MP0002060_abnormal_skin_morphology | 1.99828873 |
| 47 | MP0006082_CNS_inflammation | 1.92995923 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.90985283 |
| 49 | MP0003866_abnormal_defecation | 1.87274561 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.85104840 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.79951165 |
| 52 | MP0001873_stomach_inflammation | 1.78317282 |
| 53 | MP0005410_abnormal_fertilization | 1.71831909 |
| 54 | MP0002132_abnormal_respiratory_system | 1.71804051 |
| 55 | MP0000467_abnormal_esophagus_morphology | 1.71724761 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.71071324 |
| 57 | MP0002429_abnormal_blood_cell | 1.70087733 |
| 58 | MP0009053_abnormal_anal_canal | 1.56430740 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.55300877 |
| 60 | MP0005310_abnormal_salivary_gland | 1.51281186 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.47416195 |
| 62 | MP0000762_abnormal_tongue_morphology | 1.46712806 |
| 63 | MP0003566_abnormal_cell_adhesion | 1.43324974 |
| 64 | MP0009931_abnormal_skin_appearance | 1.42868855 |
| 65 | MP0005409_darkened_coat_color | 1.38444222 |
| 66 | MP0008961_abnormal_basal_metabolism | 1.32423912 |
| 67 | MP0003828_pulmonary_edema | 1.32062724 |
| 68 | MP0003878_abnormal_ear_physiology | 1.31353270 |
| 69 | MP0005377_hearing/vestibular/ear_phenot | 1.31353270 |
| 70 | MP0002009_preneoplasia | 1.28144017 |
| 71 | MP0003172_abnormal_lysosome_physiology | 1.25388538 |
| 72 | MP0009278_abnormal_bone_marrow | 1.24982773 |
| 73 | MP0004510_myositis | 1.21094662 |
| 74 | MP0005083_abnormal_biliary_tract | 1.19138493 |
| 75 | MP0008469_abnormal_protein_level | 1.14976520 |
| 76 | MP0002998_abnormal_bone_remodeling | 1.09160053 |
| 77 | MP0002933_joint_inflammation | 1.09132724 |
| 78 | MP0000858_altered_metastatic_potential | 1.08977923 |
| 79 | MP0004808_abnormal_hematopoietic_stem | 1.06877996 |
| 80 | MP0003941_abnormal_skin_development | 1.06305740 |
| 81 | MP0001348_abnormal_lacrimal_gland | 0.99326188 |
| 82 | MP0001853_heart_inflammation | 0.95815818 |
| 83 | MP0002277_abnormal_respiratory_mucosa | 0.95257422 |
| 84 | MP0004885_abnormal_endolymph | 0.95141889 |
| 85 | MP0004883_abnormal_blood_vessel | 0.93410296 |
| 86 | MP0000490_abnormal_crypts_of | 0.92893034 |
| 87 | MP0008260_abnormal_autophagy | 0.92879029 |
| 88 | MP0001191_abnormal_skin_condition | 0.91001617 |
| 89 | MP0004264_abnormal_extraembryonic_tissu | 0.86914149 |
| 90 | MP0005397_hematopoietic_system_phenotyp | 0.85196400 |
| 91 | MP0001545_abnormal_hematopoietic_system | 0.85196400 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.83680552 |
| 93 | MP0001661_extended_life_span | 0.83087732 |
| 94 | MP0009115_abnormal_fat_cell | 0.82361569 |
| 95 | MP0008057_abnormal_DNA_replication | 0.81385965 |
| 96 | MP0001851_eye_inflammation | 0.80429064 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.79996224 |
| 98 | MP0004185_abnormal_adipocyte_glucose | 0.79989734 |
| 99 | MP0002095_abnormal_skin_pigmentation | 0.78050198 |
| 100 | MP0009764_decreased_sensitivity_to | 0.77761494 |
| 101 | MP0008004_abnormal_stomach_pH | 0.77253317 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 0.77148364 |
| 103 | MP0004130_abnormal_muscle_cell | 0.72469697 |
| 104 | MP0003315_abnormal_perineum_morphology | 0.71694852 |
| 105 | MP0003690_abnormal_glial_cell | 0.71303124 |
| 106 | MP0002019_abnormal_tumor_incidence | 0.70512248 |
| 107 | MP0002877_abnormal_melanocyte_morpholog | 0.69556821 |
| 108 | MP0005166_decreased_susceptibility_to | 0.67290006 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.67234942 |
| 110 | MP0001663_abnormal_digestive_system | 0.66678195 |
| 111 | MP0001849_ear_inflammation | 0.64935873 |
| 112 | MP0001340_abnormal_eyelid_morphology | 0.63826351 |
| 113 | MP0009763_increased_sensitivity_to | 0.61546576 |
| 114 | MP0000249_abnormal_blood_vessel | 0.61429614 |
| 115 | MP0001346_abnormal_lacrimal_gland | 0.61249649 |
| 116 | MP0000566_synostosis | 0.60990226 |
| 117 | MP0008438_abnormal_cutaneous_collagen | 0.60010870 |
| 118 | MP0005164_abnormal_response_to | 0.59846859 |
| 119 | MP0003698_abnormal_male_reproductive | 0.57197088 |
| 120 | MP0010030_abnormal_orbit_morphology | 0.56114927 |
| 121 | MP0008874_decreased_physiological_sensi | 0.55460684 |
| 122 | MP0003091_abnormal_cell_migration | 0.55409675 |
| 123 | MP0000627_abnormal_mammary_gland | 0.54978004 |
| 124 | MP0001929_abnormal_gametogenesis | 0.54083844 |
| 125 | MP0009765_abnormal_xenobiotic_induced | 0.53211067 |
| 126 | MP0005390_skeleton_phenotype | 0.53092766 |
| 127 | MP0002282_abnormal_trachea_morphology | 0.52251975 |
| 128 | MP0002970_abnormal_white_adipose | 0.51730421 |
| 129 | MP0005535_abnormal_body_temperature | 0.50457134 |
| 130 | MP0003755_abnormal_palate_morphology | 0.50070022 |
| 131 | MP0003191_abnormal_cellular_cholesterol | 0.49367297 |
| 132 | MP0003795_abnormal_bone_structure | 0.49187835 |
| 133 | MP0002928_abnormal_bile_duct | 0.48791983 |
| 134 | MP0008569_lethality_at_weaning | 0.48427907 |
| 135 | MP0005023_abnormal_wound_healing | 0.47465762 |
| 136 | MP0002127_abnormal_cardiovascular_syste | 0.47197604 |
| 137 | MP0005451_abnormal_body_composition | 0.44273542 |
| 138 | MP0009840_abnormal_foam_cell | 0.41786073 |
| 139 | MP0002249_abnormal_larynx_morphology | 0.40405518 |
| 140 | MP0001784_abnormal_fluid_regulation | 0.39983883 |
| 141 | MP0002111_abnormal_tail_morphology | 0.39230189 |
| 142 | MP0005075_abnormal_melanosome_morpholog | 0.38504123 |
| 143 | MP0000678_abnormal_parathyroid_gland | 0.36319001 |
| 144 | MP0010352_gastrointestinal_tract_polyps | 0.34767136 |
| 145 | MP0004272_abnormal_basement_membrane | 0.31137413 |
| 146 | MP0003763_abnormal_thymus_physiology | 0.28570407 |
| 147 | MP0003385_abnormal_body_wall | 0.28471124 |
| 148 | MP0000537_abnormal_urethra_morphology | 0.28252634 |
| 149 | MP0003329_amyloid_beta_deposits | 0.25434201 |
| 150 | MP0002697_abnormal_eye_size | 0.24341769 |
| 151 | MP0003950_abnormal_plasma_membrane | 0.22914190 |
| 152 | MP0005248_abnormal_Harderian_gland | 0.22439509 |
| 153 | MP0002177_abnormal_outer_ear | 0.21250761 |
| 154 | MP0000465_gastrointestinal_hemorrhage | 0.20703317 |
| 155 | MP0003300_gastrointestinal_ulcer | 0.20337793 |
| 156 | MP0000432_abnormal_head_morphology | 0.18105885 |
| 157 | MP0004019_abnormal_vitamin_homeostasis | 0.17737378 |
| 158 | MP0004742_abnormal_vestibular_system | 0.16303348 |
| 159 | MP0003935_abnormal_craniofacial_develop | 0.15628333 |
| 160 | MP0006054_spinal_hemorrhage | 0.14886291 |
| 161 | MP0003638_abnormal_response/metabolism_ | 0.13739025 |
| 162 | MP0004858_abnormal_nervous_system | 0.13425299 |
| 163 | MP0002233_abnormal_nose_morphology | 0.13164251 |
| 164 | MP0001879_abnormal_lymphatic_vessel | 0.12960799 |
| 165 | MP0000516_abnormal_urinary_system | 0.12906461 |
| 166 | MP0005367_renal/urinary_system_phenotyp | 0.12906461 |
| 167 | MP0000604_amyloidosis | 0.12705785 |
| 168 | MP0003448_altered_tumor_morphology | 0.12245566 |
| 169 | MP0005375_adipose_tissue_phenotype | 0.11608999 |
| 170 | MP0005193_abnormal_anterior_eye | 0.10391585 |
| 171 | MP0002006_tumorigenesis | 0.10209868 |
| 172 | MP0003075_altered_response_to | 0.10184768 |
| 173 | MP0009384_cardiac_valve_regurgitation | 0.09754856 |
| 174 | MP0005666_abnormal_adipose_tissue | 0.09689716 |
| 175 | MP0005076_abnormal_cell_differentiation | 0.08833011 |
| 176 | MP0005165_increased_susceptibility_to | 0.08628438 |
| 177 | MP0010368_abnormal_lymphatic_system | 0.07496760 |
| 178 | MP0000462_abnormal_digestive_system | 0.07267098 |
| 179 | MP0003011_delayed_dark_adaptation | 0.07205105 |
| 180 | MP0000013_abnormal_adipose_tissue | 0.06792077 |
| 181 | MP0002166_altered_tumor_susceptibility | 0.06372982 |
| 182 | MP0003045_fibrosis | 0.05697122 |
| 183 | MP0005452_abnormal_adipose_tissue | 0.05394809 |
| 184 | MP0006138_congestive_heart_failure | 0.05256106 |
| 185 | MP0001730_embryonic_growth_arrest | 0.05102874 |
| 186 | MP0005508_abnormal_skeleton_morphology | 0.05025729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pili torti (HP:0003777) | 9.48146406 |
| 2 | Nail dystrophy (HP:0008404) | 7.47402882 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.93099513 |
| 4 | Abnormality of nail color (HP:0100643) | 6.06920135 |
| 5 | Abnormal hair laboratory examination (HP:0003328) | 5.99272413 |
| 6 | Fine hair (HP:0002213) | 5.56052498 |
| 7 | Fragile nails (HP:0001808) | 5.49668777 |
| 8 | Stomatitis (HP:0010280) | 4.95915582 |
| 9 | Alopecia of scalp (HP:0002293) | 4.86933619 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.81281004 |
| 11 | Myositis (HP:0100614) | 4.76488530 |
| 12 | Recurrent abscess formation (HP:0002722) | 4.75910189 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.65567199 |
| 14 | T lymphocytopenia (HP:0005403) | 4.61217755 |
| 15 | Follicular hyperkeratosis (HP:0007502) | 4.59178196 |
| 16 | Onycholysis (HP:0001806) | 4.57891396 |
| 17 | Palmoplantar hyperkeratosis (HP:0000972) | 4.52443393 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.49595053 |
| 19 | Thick nail (HP:0001805) | 4.48842172 |
| 20 | Pustule (HP:0200039) | 4.42619451 |
| 21 | Palmar hyperkeratosis (HP:0010765) | 4.25289283 |
| 22 | Abnormality of T cell number (HP:0011839) | 4.24266454 |
| 23 | Recurrent fungal infections (HP:0002841) | 4.22685458 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 4.14606323 |
| 25 | Right ventricular cardiomyopathy (HP:0011663) | 4.13600097 |
| 26 | Plantar hyperkeratosis (HP:0007556) | 4.11173984 |
| 27 | Abnormality of macrophages (HP:0004311) | 4.06143769 |
| 28 | Prolonged bleeding time (HP:0003010) | 3.86471796 |
| 29 | Increased IgE level (HP:0003212) | 3.85750279 |
| 30 | Papilledema (HP:0001085) | 3.83575824 |
| 31 | Orchitis (HP:0100796) | 3.80427658 |
| 32 | Spontaneous hematomas (HP:0007420) | 3.78975873 |
| 33 | Meningitis (HP:0001287) | 3.77998861 |
| 34 | Obstructive lung disease (HP:0006536) | 3.73869941 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 3.73869941 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 3.69267251 |
| 37 | Sparse eyelashes (HP:0000653) | 3.68860878 |
| 38 | Optic neuritis (HP:0100653) | 3.67775322 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 3.67775322 |
| 40 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.64930670 |
| 41 | Abnormality of T cells (HP:0002843) | 3.63619501 |
| 42 | Mediastinal lymphadenopathy (HP:0100721) | 3.45600867 |
| 43 | Encephalitis (HP:0002383) | 3.39964333 |
| 44 | Granulocytopenia (HP:0001913) | 3.32492692 |
| 45 | Oral leukoplakia (HP:0002745) | 3.32037630 |
| 46 | Recurrent skin infections (HP:0001581) | 3.31631006 |
| 47 | Vasculitis (HP:0002633) | 3.27570467 |
| 48 | Chest pain (HP:0100749) | 3.24545739 |
| 49 | Inflammation of the large intestine (HP:0002037) | 3.20169824 |
| 50 | Hypochromic microcytic anemia (HP:0004840) | 3.19914539 |
| 51 | Erythema (HP:0010783) | 3.19563843 |
| 52 | Gastrointestinal inflammation (HP:0004386) | 3.18465884 |
| 53 | Milia (HP:0001056) | 3.18275260 |
| 54 | Amelogenesis imperfecta (HP:0000705) | 3.16202636 |
| 55 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.13476885 |
| 56 | Recurrent cutaneous fungal infections (HP:0011370) | 3.13476885 |
| 57 | Recurrent viral infections (HP:0004429) | 3.11174341 |
| 58 | Hypochromic anemia (HP:0001931) | 3.10823692 |
| 59 | Abnormality of the frontal sinuses (HP:0002687) | 3.09230647 |
| 60 | Lymphopenia (HP:0001888) | 3.07891482 |
| 61 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.01085485 |
| 62 | Leukocytosis (HP:0001974) | 3.00900674 |
| 63 | Severe combined immunodeficiency (HP:0004430) | 3.00636249 |
| 64 | Gingivitis (HP:0000230) | 2.98395721 |
| 65 | Parakeratosis (HP:0001036) | 2.98149221 |
| 66 | Congenital, generalized hypertrichosis (HP:0004540) | 2.88862758 |
| 67 | Verrucae (HP:0200043) | 2.86077873 |
| 68 | Papilloma (HP:0012740) | 2.86077873 |
| 69 | Abnormality of T cell physiology (HP:0011840) | 2.83193523 |
| 70 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.83008123 |
| 71 | Cellulitis (HP:0100658) | 2.80069667 |
| 72 | Eosinophilia (HP:0001880) | 2.78744211 |
| 73 | Intention tremor (HP:0002080) | 2.76539747 |
| 74 | IgM deficiency (HP:0002850) | 2.75197714 |
| 75 | Curly hair (HP:0002212) | 2.72326179 |
| 76 | Colitis (HP:0002583) | 2.68285464 |
| 77 | Ridged nail (HP:0001807) | 2.67586353 |
| 78 | Urticaria (HP:0001025) | 2.66007466 |
| 79 | Epistaxis (HP:0000421) | 2.64771361 |
| 80 | Increased IgM level (HP:0003496) | 2.62969177 |
| 81 | Torticollis (HP:0000473) | 2.60461628 |
| 82 | Slow saccadic eye movements (HP:0000514) | 2.59222256 |
| 83 | Pulmonary infiltrates (HP:0002113) | 2.55120090 |
| 84 | Abnormality of the fingertips (HP:0001211) | 2.53134185 |
| 85 | Abnormality of eosinophils (HP:0001879) | 2.53053531 |
| 86 | Basal cell carcinoma (HP:0002671) | 2.49782905 |
| 87 | Hemoptysis (HP:0002105) | 2.47269750 |
| 88 | Neck muscle weakness (HP:0000467) | 2.47117255 |
| 89 | Combined immunodeficiency (HP:0005387) | 2.45356903 |
| 90 | Erythroderma (HP:0001019) | 2.43334349 |
| 91 | Natal tooth (HP:0000695) | 2.43168844 |
| 92 | Autoimmune hemolytic anemia (HP:0001890) | 2.42576070 |
| 93 | Nasal polyposis (HP:0100582) | 2.41120221 |
| 94 | Dry hair (HP:0011359) | 2.39635173 |
| 95 | Recurrent bronchitis (HP:0002837) | 2.39415641 |
| 96 | Aplasia cutis congenita (HP:0001057) | 2.38042176 |
| 97 | Episodic fever (HP:0001954) | 2.37594812 |
| 98 | Pulmonary embolism (HP:0002204) | 2.37006976 |
| 99 | Hypoplasia of the thymus (HP:0000778) | 2.34727620 |
| 100 | Advanced eruption of teeth (HP:0006288) | 2.28607252 |
| 101 | Gingival bleeding (HP:0000225) | 2.27161342 |
| 102 | Microcytic anemia (HP:0001935) | 2.25842783 |
| 103 | Agammaglobulinemia (HP:0004432) | 2.22387325 |
| 104 | Abnormal blistering of the skin (HP:0008066) | 2.22347366 |
| 105 | Craniofacial dystonia (HP:0012179) | 2.20631323 |
| 106 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.14887091 |
| 107 | Seborrheic dermatitis (HP:0001051) | 2.13277835 |
| 108 | IgG deficiency (HP:0004315) | 2.11377960 |
| 109 | Arterial thrombosis (HP:0004420) | 2.11213951 |
| 110 | Sepsis (HP:0100806) | 2.10336389 |
| 111 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.07576017 |
| 112 | Skin ulcer (HP:0200042) | 2.05884833 |
| 113 | Gangrene (HP:0100758) | 2.03878214 |
| 114 | Focal dystonia (HP:0004373) | 2.02006460 |
| 115 | Osteomyelitis (HP:0002754) | 2.00693999 |
| 116 | Subacute progressive viral hepatitis (HP:0006572) | 2.00150316 |
| 117 | Hypotrichosis (HP:0001006) | 14.9134299 |
| 118 | Abnormality of hair growth rate (HP:0011363) | 11.7421950 |
| 119 | Slow-growing hair (HP:0002217) | 11.7421950 |
| 120 | Woolly hair (HP:0002224) | 11.4441054 |
| 121 | Brittle hair (HP:0002299) | 10.8462983 |
| 122 | Hypohidrosis (HP:0000966) | 1.99622146 |
| 123 | Anorexia (HP:0002039) | 1.98782728 |
| 124 | Viral hepatitis (HP:0006562) | 1.98771713 |
| 125 | Acute hepatic failure (HP:0006554) | 1.96678246 |
| 126 | Joint swelling (HP:0001386) | 1.96614853 |
| 127 | Difficulty walking (HP:0002355) | 1.94934119 |
| 128 | Abnormality of the pupil (HP:0000615) | 1.92145768 |
| 129 | Abnormality of the pleura (HP:0002103) | 1.91911118 |
| 130 | Ventricular tachycardia (HP:0004756) | 1.91431895 |
| 131 | Corneal erosion (HP:0200020) | 1.91197995 |
| 132 | Abnormality of the nasal mucosa (HP:0000433) | 1.89774507 |
| 133 | Gastrointestinal stroma tumor (HP:0100723) | 1.87189069 |
| 134 | Abnormality of the dental root (HP:0006486) | 1.87148336 |
| 135 | Taurodontia (HP:0000679) | 1.87148336 |
| 136 | Abnormality of permanent molar morphology (HP:0011071) | 1.87148336 |
| 137 | Pruritus (HP:0000989) | 1.86153329 |
| 138 | Severe visual impairment (HP:0001141) | 1.85547932 |
| 139 | Palmoplantar keratoderma (HP:0000982) | 1.85322437 |
| 140 | Glomerulopathy (HP:0100820) | 1.84277868 |
| 141 | Ventricular fibrillation (HP:0001663) | 1.84233389 |
| 142 | Abnormality of molar morphology (HP:0011070) | 1.82465343 |
| 143 | Abnormality of molar (HP:0011077) | 1.82465343 |
| 144 | Abnormality of the parietal bone (HP:0002696) | 1.81834382 |
| 145 | Lymphoma (HP:0002665) | 1.81236371 |
| 146 | Petechiae (HP:0000967) | 1.79008499 |
| 147 | Abnormal platelet volume (HP:0011876) | 1.77919905 |
| 148 | Autoimmune thrombocytopenia (HP:0001973) | 1.77537697 |
| 149 | Abnormality of dental color (HP:0011073) | 1.76316595 |
| 150 | Concave nail (HP:0001598) | 1.75366028 |
| 151 | Asymmetric septal hypertrophy (HP:0001670) | 1.74903501 |
| 152 | Absent eyelashes (HP:0000561) | 1.74743201 |
| 153 | Abnormality of the columella (HP:0009929) | 1.73147924 |
| 154 | Teleangiectasia of the skin (HP:0100585) | 1.72692704 |
| 155 | Hemiplegia (HP:0002301) | 1.71182458 |
| 156 | Widely patent fontanelles and sutures (HP:0004492) | 1.67473827 |
| 157 | Fatigable weakness (HP:0003473) | 1.64817249 |
| 158 | Abnormality of the neuromuscular junction (HP:0003398) | 1.64817249 |
| 159 | Abnormality of the dental pulp (HP:0006479) | 1.63449996 |
| 160 | Recurrent corneal erosions (HP:0000495) | 1.59998733 |
| 161 | Blepharitis (HP:0000498) | 1.54984279 |
| 162 | Abnormality of the aortic arch (HP:0012303) | 1.52483837 |
| 163 | Amniotic constriction ring (HP:0009775) | 1.52385070 |
| 164 | Abnormality of placental membranes (HP:0011409) | 1.52385070 |
| 165 | Unilateral renal agenesis (HP:0000122) | 1.48677540 |
| 166 | Heterogeneous (HP:0001425) | 1.45083646 |
| 167 | Sudden death (HP:0001699) | 1.44399125 |
| 168 | Acanthosis nigricans (HP:0000956) | 1.42050254 |
| 169 | Carious teeth (HP:0000670) | 1.37350002 |
| 170 | Hyporeflexia of lower limbs (HP:0002600) | 1.36167856 |
| 171 | Keratoconjunctivitis sicca (HP:0001097) | 1.34170706 |
| 172 | Lip pit (HP:0100267) | 1.33897421 |
| 173 | Anonychia (HP:0001798) | 1.32687909 |
| 174 | Craniofacial hyperostosis (HP:0004493) | 1.32130987 |
| 175 | Autoamputation (HP:0001218) | 1.30030755 |
| 176 | Neonatal onset (HP:0003623) | 1.27534826 |
| 177 | Achilles tendon contracture (HP:0001771) | 1.24443176 |
| 178 | Abnormality of the fingernails (HP:0001231) | 1.23887283 |
| 179 | Variable expressivity (HP:0003828) | 1.23278605 |
| 180 | Widely spaced teeth (HP:0000687) | 1.22690143 |
| 181 | Selective tooth agenesis (HP:0001592) | 1.22670793 |
| 182 | Sparse scalp hair (HP:0002209) | 1.20512548 |
| 183 | Keratoconjunctivitis (HP:0001096) | 1.17907304 |
| 184 | Laryngomalacia (HP:0001601) | 1.17807908 |
| 185 | Abnormality of the Achilles tendon (HP:0005109) | 1.17530846 |
| 186 | Distal lower limb muscle weakness (HP:0009053) | 1.14969710 |
| 187 | Ectropion (HP:0000656) | 1.14187859 |
| 188 | Hypergammaglobulinemia (HP:0010702) | 1.11266039 |
| 189 | Abnormality of the gastric mucosa (HP:0004295) | 1.10453508 |
| 190 | Epidermoid cyst (HP:0200040) | 1.08237757 |
| 191 | Wide cranial sutures (HP:0010537) | 1.06144303 |
| 192 | Furrowed tongue (HP:0000221) | 1.04739685 |
| 193 | Hyperhidrosis (HP:0000975) | 1.04137750 |
| 194 | Bronchomalacia (HP:0002780) | 1.03979100 |
| 195 | Lack of skin elasticity (HP:0100679) | 1.02690832 |
| 196 | Neonatal death (HP:0003811) | 1.02550380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.93867918 |
| 2 | MAP3K6 | 4.62077970 |
| 3 | EPHA2 | 4.37638400 |
| 4 | FER | 4.15979676 |
| 5 | MAPKAPK3 | 4.05843145 |
| 6 | ERN1 | 3.77087635 |
| 7 | RIPK4 | 3.44058631 |
| 8 | PRPF4B | 3.37086433 |
| 9 | TAOK1 | 3.11293458 |
| 10 | EPHB2 | 3.04937737 |
| 11 | TXK | 3.02298077 |
| 12 | MAP3K3 | 2.79632356 |
| 13 | TRIB3 | 2.67181260 |
| 14 | ZAP70 | 2.55573815 |
| 15 | MAP3K2 | 2.53453446 |
| 16 | LATS1 | 2.52635500 |
| 17 | TNK2 | 2.25226432 |
| 18 | FES | 2.24930239 |
| 19 | CSK | 2.22538455 |
| 20 | EEF2K | 2.07781059 |
| 21 | SIK3 | 2.07266051 |
| 22 | MAP3K13 | 2.01186669 |
| 23 | MAP3K11 | 1.99852507 |
| 24 | BTK | 1.94334476 |
| 25 | RPS6KB2 | 1.92051346 |
| 26 | JAK3 | 1.85505126 |
| 27 | NLK | 1.84037147 |
| 28 | ITK | 1.77078348 |
| 29 | LATS2 | 1.72807402 |
| 30 | SYK | 1.71750389 |
| 31 | HCK | 1.68965051 |
| 32 | EPHB1 | 1.68576145 |
| 33 | MARK3 | 1.67671695 |
| 34 | CAMKK2 | 1.67476475 |
| 35 | IRAK4 | 1.62144623 |
| 36 | MAP2K6 | 1.59244732 |
| 37 | SIK2 | 1.55837429 |
| 38 | LCK | 1.41521203 |
| 39 | SMG1 | 1.36557878 |
| 40 | FGFR4 | 1.33368897 |
| 41 | MAP3K14 | 1.31876494 |
| 42 | IKBKE | 1.29154616 |
| 43 | TTN | 1.28870000 |
| 44 | CAMKK1 | 1.27779940 |
| 45 | KSR2 | 1.27503592 |
| 46 | BCR | 1.26949351 |
| 47 | MARK2 | 1.25986442 |
| 48 | PIK3CG | 1.25431648 |
| 49 | MAP3K1 | 1.25347603 |
| 50 | PKN2 | 1.24965927 |
| 51 | CDK12 | 1.21730044 |
| 52 | FGFR2 | 1.21599339 |
| 53 | RIPK1 | 1.18850197 |
| 54 | TAOK3 | 1.18696152 |
| 55 | BMX | 1.18439777 |
| 56 | PASK | 1.17881830 |
| 57 | CDK6 | 1.17097495 |
| 58 | NME1 | 1.16509598 |
| 59 | BLK | 1.13779685 |
| 60 | FGFR3 | 1.13021591 |
| 61 | MAPKAPK2 | 1.08431599 |
| 62 | PDGFRA | 1.07041501 |
| 63 | LYN | 1.04814339 |
| 64 | BRD4 | 1.02011492 |
| 65 | PTK6 | 1.01163601 |
| 66 | MAP2K3 | 1.00522812 |
| 67 | HIPK2 | 1.00344688 |
| 68 | TEC | 0.99157019 |
| 69 | PDK1 | 0.97811185 |
| 70 | MAP3K7 | 0.96429298 |
| 71 | MAP3K9 | 0.95514425 |
| 72 | STK10 | 0.95164260 |
| 73 | MAP3K10 | 0.93463766 |
| 74 | LRRK2 | 0.91186542 |
| 75 | STK38L | 0.88732277 |
| 76 | MAP2K4 | 0.88728914 |
| 77 | RPS6KA4 | 0.84633824 |
| 78 | PTK2 | 0.83164758 |
| 79 | STK38 | 0.82261361 |
| 80 | MST1R | 0.82153081 |
| 81 | YES1 | 0.80014492 |
| 82 | PRKCQ | 0.79719209 |
| 83 | PIM2 | 0.79419860 |
| 84 | PAK3 | 0.78777069 |
| 85 | SIK1 | 0.77865679 |
| 86 | FGFR1 | 0.76195714 |
| 87 | ERBB4 | 0.75098525 |
| 88 | MAP2K1 | 0.74450591 |
| 89 | CDK4 | 0.73880345 |
| 90 | TBK1 | 0.72091421 |
| 91 | MAPK7 | 0.70768407 |
| 92 | CDC42BPA | 0.70153500 |
| 93 | FGR | 0.70132935 |
| 94 | PAK4 | 0.69686181 |
| 95 | PBK | 0.68810907 |
| 96 | TYK2 | 0.66218712 |
| 97 | TESK2 | 0.65568226 |
| 98 | PRKD1 | 0.64959411 |
| 99 | DYRK1B | 0.64801193 |
| 100 | IKBKB | 0.64667538 |
| 101 | DDR2 | 0.62038821 |
| 102 | WNK1 | 0.61291191 |
| 103 | PDPK1 | 0.60270856 |
| 104 | CDK19 | 0.60147608 |
| 105 | CSF1R | 0.60136804 |
| 106 | TESK1 | 0.59998463 |
| 107 | MAP3K5 | 0.56970794 |
| 108 | JAK1 | 0.56408212 |
| 109 | PRKCI | 0.55856810 |
| 110 | MELK | 0.55127465 |
| 111 | TRPM7 | 0.54205698 |
| 112 | PLK4 | 0.54050758 |
| 113 | TYRO3 | 0.53968094 |
| 114 | PRKD2 | 0.53810360 |
| 115 | PAK6 | 0.53717883 |
| 116 | PIM1 | 0.53436577 |
| 117 | MET | 0.52711163 |
| 118 | NEK2 | 0.52059352 |
| 119 | RET | 0.51824871 |
| 120 | PRKCH | 0.51088763 |
| 121 | PDGFRB | 0.50840189 |
| 122 | CAMK1D | 0.50161514 |
| 123 | RPS6KA1 | 0.49206723 |
| 124 | ERBB2 | 0.48781468 |
| 125 | TGFBR1 | 0.47985729 |
| 126 | PAK2 | 0.46214511 |
| 127 | NTRK2 | 0.45970495 |
| 128 | MAPK11 | 0.45036511 |
| 129 | CAMK4 | 0.43791523 |
| 130 | EPHA3 | 0.43465344 |
| 131 | KIT | 0.43436480 |
| 132 | CLK1 | 0.43383821 |
| 133 | GRK6 | 0.42258134 |
| 134 | ALK | 0.41033833 |
| 135 | CSNK1E | 0.40780862 |
| 136 | UHMK1 | 0.40024894 |
| 137 | SGK3 | 0.38844923 |
| 138 | GSK3A | 0.38760247 |
| 139 | MAPK12 | 0.38587702 |
| 140 | MAP2K2 | 0.36963366 |
| 141 | JAK2 | 0.35639351 |
| 142 | MST4 | 0.35565502 |
| 143 | MAP3K8 | 0.34046170 |
| 144 | ILK | 0.33887688 |
| 145 | RPS6KL1 | 0.33762627 |
| 146 | RPS6KC1 | 0.33762627 |
| 147 | STK24 | 0.33327437 |
| 148 | FYN | 0.30846879 |
| 149 | PTK2B | 0.30737621 |
| 150 | SGK2 | 0.30096829 |
| 151 | PHKG1 | 0.29943401 |
| 152 | PHKG2 | 0.29943401 |
| 153 | NEK6 | 0.29750341 |
| 154 | STK11 | 0.28544168 |
| 155 | NEK1 | 0.27182571 |
| 156 | ERBB3 | 0.27026788 |
| 157 | TGFBR2 | 0.24971315 |
| 158 | CSNK1G1 | 0.23827873 |
| 159 | CSNK1A1 | 0.23274391 |
| 160 | ABL2 | 0.22394286 |
| 161 | CSNK1A1L | 0.22033803 |
| 162 | CSNK1G3 | 0.21944662 |
| 163 | ROCK2 | 0.21901990 |
| 164 | PRKACG | 0.21735818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 5.12567676 |
| 2 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 5.09572870 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.29691494 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.24341567 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.85806303 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.76528888 |
| 7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.72954431 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51179700 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.45973566 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.40467164 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.39955270 |
| 12 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.26988554 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.13959063 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.06398105 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.93648693 |
| 16 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.92150625 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.90146430 |
| 18 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.82009777 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.77838793 |
| 20 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.76732689 |
| 21 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.75424906 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72360722 |
| 23 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.66737041 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60954708 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.60100349 |
| 26 | Melanogenesis_Homo sapiens_hsa04916 | 1.57676190 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.57109428 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.55902106 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.55575600 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.52556206 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50804508 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47857678 |
| 33 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.42470674 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.39695351 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.39074808 |
| 36 | Thyroid cancer_Homo sapiens_hsa05216 | 1.36958256 |
| 37 | Bladder cancer_Homo sapiens_hsa05219 | 1.35624576 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.35109150 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.34645923 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31840577 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31585892 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.31031444 |
| 43 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.30867242 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.29464272 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.28358705 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.26914322 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.25855978 |
| 48 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.22164024 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20727341 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19437325 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15995544 |
| 52 | Colorectal cancer_Homo sapiens_hsa05210 | 1.14463378 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.12139182 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.11879357 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.11589589 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10693356 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 1.09783316 |
| 58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.09359997 |
| 59 | Tight junction_Homo sapiens_hsa04530 | 1.08843317 |
| 60 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.05166748 |
| 61 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04357944 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.03872900 |
| 63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02982241 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01050329 |
| 65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00790462 |
| 66 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.00569537 |
| 67 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.99304415 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.98059431 |
| 69 | Long-term potentiation_Homo sapiens_hsa04720 | 0.97972068 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.96688980 |
| 71 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.93295749 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.93102947 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92934957 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92329798 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92021287 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 0.91478663 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89518972 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89481756 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88752655 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86948824 |
| 81 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.86638750 |
| 82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.86239092 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85720735 |
| 84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83559258 |
| 85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82791815 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82543388 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.81844354 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81791481 |
| 89 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81089534 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.79470980 |
| 91 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.76890214 |
| 92 | Long-term depression_Homo sapiens_hsa04730 | 0.74517411 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.73859249 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.73612760 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72976778 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72835168 |
| 97 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.72755988 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71838141 |
| 99 | Phagosome_Homo sapiens_hsa04145 | 0.71389663 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71252565 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.70449207 |
| 102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69483739 |
| 103 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68471045 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65427547 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65039921 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64876412 |
| 107 | Legionellosis_Homo sapiens_hsa05134 | 0.64832524 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63807141 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.63140548 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62216371 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62001008 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61461000 |
| 113 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60224776 |
| 114 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.59764323 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59560907 |
| 116 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.58950016 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58739579 |
| 118 | Gap junction_Homo sapiens_hsa04540 | 0.57940989 |
| 119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57387192 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56232498 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.55888116 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55777797 |
| 123 | Shigellosis_Homo sapiens_hsa05131 | 0.54934891 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54932622 |
| 125 | Asthma_Homo sapiens_hsa05310 | 0.54313701 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54164033 |
| 127 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53266464 |
| 128 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50651839 |
| 129 | Renin secretion_Homo sapiens_hsa04924 | 0.50423259 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49870837 |
| 131 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49836736 |
| 132 | Salmonella infection_Homo sapiens_hsa05132 | 0.49156513 |
| 133 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.48815428 |
| 134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48439252 |
| 135 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48433264 |
| 136 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47990832 |
| 137 | Phototransduction_Homo sapiens_hsa04744 | 0.46866587 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46010324 |
| 139 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45796914 |
| 140 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44170237 |
| 141 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43132480 |
| 142 | Focal adhesion_Homo sapiens_hsa04510 | 0.42615349 |
| 143 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42288743 |
| 144 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41855812 |
| 145 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41778493 |
| 146 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.41674283 |
| 147 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.41410884 |
| 148 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41315448 |
| 149 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41148528 |
| 150 | Salivary secretion_Homo sapiens_hsa04970 | 0.41058603 |
| 151 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40478099 |
| 152 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39730647 |
| 153 | Prion diseases_Homo sapiens_hsa05020 | 0.39642266 |
| 154 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39501311 |
| 155 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.39376621 |
| 156 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.39374841 |
| 157 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39360053 |
| 158 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39080638 |
| 159 | Platelet activation_Homo sapiens_hsa04611 | 0.38763115 |
| 160 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37898326 |
| 161 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.36505897 |
| 162 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35957893 |
| 163 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.35474581 |
| 164 | Melanoma_Homo sapiens_hsa05218 | 0.35183077 |
| 165 | Tuberculosis_Homo sapiens_hsa05152 | 0.33503639 |
| 166 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.33404039 |
| 167 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.33265828 |

